MedPath

Reducing impulsivity in repeat violent offenders using a selective serotonin reuptake inhibitor (sertraline)

Phase 4
Recruiting
Conditions
Offending behaviour
Impulsivity
Anger
Aggression
Other - Research that is not of generic health relevance and not applicable to specific health categories listed above
Registration Number
ACTRN12613000442707
Lead Sponsor
niversity of NSW
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Male
Target Recruitment
460
Inclusion Criteria

Male sex;
Over the age of 18 years;
Prior conviction for 2 or more violent offences;
Score of 70 or above on the Barratt Impulsiveness Scale;
Medically fit to undertake the trial;
Able to provide informed consent.

Exclusion Criteria

Current use of any serotonergic drug (e.g. SSRI, SNRI, TCA);
History of adverse drug reactions to SSRI;
Current use of any anti-psychotic medication;
Severe mental illness
Considered to be at high risk of suicide;
Anticipation of receiving a custodial sentence;
Significant renal or hepatic impairment;
Inability to provide informed consent;
Conviction for murder or child sexual assault;
Impending deportation, moving interstate, returning to a remote/inaccessible area.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Offending behaviour. <br><br>Re-offending will be determined by linking the participant list to the NSW Bureau of Crime Statistics Reoffending Database (ROD) which records individuals' criminal court appearances over time.[Assessed retrospectively at 12 months following commencement of the intervention or control treatment. ]
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath